Biopharma executive · Scientific advisory · Lausanne
The decisions that shape a pipeline are rarely purely scientific.
With twenty years in the biopharma space and senior roles across Janssen, Lonza, and GSK, I work on the decisions that shape pipelines: when assets need direction, when programs require hard calls, and when science must translate into outcomes that hold up commercially and operationally. biodesyn is my advisory practice for selective consulting alongside executive and board roles.
Three interlocking dimensions
Science
The molecular-level foundation for pipeline decisions that stick. From target tractability and protein engineering to developability and go/no-go advisory, grounded in twenty years in the biopharma space across biologics and vaccines.
Strategy
Portfolio direction, cross-functional alignment, and program leadership from early discovery through NME declaration. Translating scientific progress into organisational outcomes that hold under pressure.
Business Acumen
Governance, financial oversight, and board-level judgement, with the commercial literacy to sit in resource allocation discussions as a peer.
What we do
Where biodesyn operates
I take on selective advisory work when there is a clear fit. The work ranges from board-level guidance to hands-on program leadership, including building scripts or workflows when teams need practical tools.
Scientific Advisory
Target selection, protein design, developability strategy, AI/ML integration, and pipeline prioritisation for biologics and vaccine programs.
Pipeline Leadership
Program leadership, cross-functional coordination, stage-gate advisory, and translational strategy from discovery through preclinical milestones.
Organisational Strategy
Function-building, team performance, Disciplined Agile implementation, cross-functional alignment for R&D environments, and hands-on workflow or automation work when teams need practical tools to move faster.
Governance and Board Roles
Independent scientific judgement for boards and scientific advisory boards. R&D strategy audit, portfolio risk assessment, and financial oversight where deep pipeline expertise is relevant.
The SynMinds Series
A common language for high-performing teams.
Biology, computation, and operations teams often use different mental models, and that slows decisions down. I built the SynMinds Series as short reference materials for cross-functional teams: shared vocabulary and frameworks that make collaboration easier. They started as internal documents and are now available on request.
Antibodies Decoded
Foundations for Discovery & Development
AI Demystified
From Concepts to Applications
Disciplined Agile Unlocked
Frameworks for High-Performing Teams
Viral Vaccines Blueprint
Foundations for Discovery
Available upon request. Tailored versions for specific team contexts can be discussed.
Contact
Get in touch.
I am actively open to senior R&D executive roles at director level and above, and to board or SAB mandates. I also take on selective consulting through biodesyn when the fit is right.
Location
Lausanne, Switzerland
Confidentiality
biodesyn operates under strict confidentiality agreements and applies secure data-handling practices aligned with pharmaceutical industry standards.